Publication Author: Sullivan_Sean

• Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.

  Campbell JD, Gries KS, Watanabe JH, Ravelo A, Dmochowski RR, Sullivan SD. Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence. BMC Urol. 2009 Nov 20;9:18. Review.

  rakerr2

  November 20, 2009

• A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus.

  Sullivan SD, Alfonso-Cristancho R, Conner C, Hammer M, Blonde L. A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus. Pharmacotherapy. 2009 Nov;29(11):1280-8.

  rakerr2

  November 1, 2009

• Present and future costs of COPD in Iceland and Norway: results from the BOLD study.

  Nielsen R, Johannessen A, Benediktsdottir B, Gislason T, Buist AS, Gulsvik A, Sullivan SD, Lee TA. Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J. 2009 Oct;34(4):850-7. doi: 10.1183/09031936.00166108. Epu

  rakerr2

  October 1, 2009

• Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.

  Delea TE, Sofrygin O, Palmer JL, Lau H, Munk VC, Sung J, Charney A, Parving HH, Sullivan SD. Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria. J Am Soc Nephrol. 2009 Oct;20(10):2205-13. doi: 10.1681/ASN.2008111144. Epub 20

  rakerr2

  October 1, 2009

• Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals.

  Carlson JJ, Garrison LP Jr, Sullivan SD. Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals. J Manag Care Pharm. 2009 Oct;15(8):683-7.

  rakerr2

  October 1, 2009

• Association between antiepileptic drug switching and epilepsy-related events.

  Hansen RN, Campbell JD, Sullivan SD. Association between antiepileptic drug switching and epilepsy-related events. Epilepsy Behav. 2009 Aug;15(4):481-5. doi: 10.1016/j.yebeh.2009.05.019. Epub 2009 Jul 16.

  rakerr2

  August 1, 2009

• An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

  Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ,

  rakerr2

  July 1, 2009

• The impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa.

  Song X, Long SR, Marder WD, Sullivan SD, Kallich J. The impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa. Ann Pharmacother. 2009 Jul;43(7):1203-10. doi: 10.1345/aph.1L590. Epub 2009 Jul 7.

  rakerr2

  July 1, 2009

• Health technology assessment in health-care decisions in the United States.

  Sullivan SD, Watkins J, Sweet B, Ramsey SD. Health technology assessment in health-care decisions in the United States. Value Health. 2009 Jun;12 Suppl 2:S39-44. doi: 10.1111/j.1524-4733.2009.00557.x.

  rakerr2

  June 1, 2009

• The transferability of economic data: a difficult endeavor.

  Sullivan SD. The transferability of economic data: a difficult endeavor. Value Health. 2009 Jun;12(4):408. doi: 10.1111/j.1524-4733.2008.00491.x. Epub 2009 Jan 12.

  rakerr2

  June 1, 2009